Scholars Central

ArticlePublished 31 Aug 2024

The Associated Benefits of Low Molecular Weight Heparin in Case of In Vitro Fertilization-A Systematic Review

Authors: Maha Almehiyawi, Orjwan S. Khayat, Douha Bannan, Samah Alshehri, Hussam Kutbi, Ghadah H. Alshehri, Ghadah A. Assiri, Mohammed Z. Nasrullah, Ahmed Aljabri, Mohannad Alshibani

Indian Journal of Pharmaceutical Sciences

Volume 86 · Issue 4 · Pages 1522–1528

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A lack of definitive research exists regarding the application of low molecular weight heparin during pregnancy in connection with in vitro fertilization. The objective of this analysis is to determine if low molecular weight heparin enhances the success of pregnancies in women who do not have thrombophilia and are undergoing in vitro fertilization treatment. A comprehensive search was conducted across four databases (PubMed/MEDLINE, ScienceDirect, Scopus, and the Cochrane Library) for articles written in English from 2000 to 2020. All research methodologies evaluating the influence of low molecular weight heparin during in vitro fertilization on live birth rate, clinical pregnancy rate, and miscarriage rate were included. Individual case reports and studies focusing on women with hereditary or acquired thrombophilia, hormonal, or autoimmune disorders were excluded. Out of 3490 screened studies, 5 studies satisfied the selection requirements (consisting of 4 randomized and 1 observational study). The review encompassed a total of 1006 women, with 520 receiving low-molecular-weight heparin and 486 belonging to the control group. No significant differences were observed between the low molecular weight heparin and control groups in any of the evaluated outcomes (live birth rate, clinical pregnancy rate, miscarriage rate). It is important to note that the duration and dosage of low molecular weight heparin exhibited considerable variation across the studies included. While it may have a potential benefit especially in terms of live birth rate and clinical pregnancy rate, the current evidence doesn’t imply a significant influence of low-molecular-weight heparin on in vitro fertilization treatment outcomes in terms of successful pregnancy rates for women without thrombophilia. Additional research is needed to evaluate the actual role of low molecular weight heparin as a treatment during in vitro fertilization procedures.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Maha Almehiyawi”
  • BylineArticles whose byline prints “Orjwan S. Khayat”
  • BylineArticles whose byline prints “Douha Bannan”
  • BylineArticles whose byline prints “Samah Alshehri”
  • BylineArticles whose byline prints “Hussam Kutbi”
  • BylineArticles whose byline prints “Ghadah H. Alshehri”
  • BylineArticles whose byline prints “Ghadah A. Assiri”
  • BylineArticles whose byline prints “Mohammed Z. Nasrullah”